Drug:
Reaction: BLOOD GLUCOSE INCREASED
20260101 - 20261231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 26419050 |
US |
80 | 1 |
Blood glucose increased, Product storage error, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 602 | 26419214 |
US |
60 | 1 |
Vision blurred, Blood glucose increased, Overdose, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 603 | 26419280 |
US |
58 | 1 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, |
||||
| 604 | 26419281 |
US |
75 | 2 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 605 | 26419302 |
US |
33 | 2 |
Wrong technique in product usage process, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 606 | 26419387 |
US |
48 | 2 |
Hypothyroidism, Hypertension, Palmar-plantar erythrodysaesthesia syndrome, Dysgeusia, Fatigue, Rash, Constipation, Muscle spasms, Dry skin, Abdominal discomfort, Ocular hyperaemia, Salivary hypersecretion, Nasopharyngitis, Hot flush, Blood glucose increased, Dermatitis, Dyspnoea, Productive cough, |
||||
NIVOLUMAB, CABOZANTINIB, IPILIMUMAB, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NALOXONE HCL, MONTELUKAST SODIUM, MONTELUKAST, FUROSEMIDE, FENOFIBRATE, CETIRIZINE HCL, CETIRIZINE, ALBUTEROL SULFATE, LIRAGLUTIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, REGADENOSON, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FERROUS SULFATE, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 607 | 26419503 |
US |
80 | 2 |
Feeling abnormal, Blood glucose increased, Device issue, Product storage error, Incorrect dose administered by device, |
||||
INSULIN GLARGINE, |
||||
| 608 | 26418066 |
CN |
58 | 1 |
Immune-mediated optic neuritis, Blood glucose increased, |
||||
CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 609 | 26418095 |
US |
66 | 2 |
Alopecia, Exercise tolerance decreased, Muscle tightness, Headache, Migraine, Blood immunoglobulin G decreased, CD3 lymphocytes decreased, Cell marker increased, Cell marker decreased, CD4 lymphocytes increased, CD4 lymphocytes decreased, Natural killer cell count decreased, CD19 lymphocytes decreased, CD45 expression decreased, CD45 expression decreased, Blood glucose increased, Blood alkaline phosphatase decreased, Cervical radiculopathy, Leukopenia, Immunosuppression, Urinary tract infection, Vitamin D deficiency, Off label use, CD8 lymphocytes decreased, Occipital neuralgia, Product prescribing error, |
||||
OCRELIZUMAB, OCRELIZUMAB, BACLOFEN, CELECOXIB, DULOXETINE HYDROCHLORIDE, DULOXETINE, GABAPENTIN, HYDROXYCHLOROQUINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PROGESTERONE, CYCLOSPORINE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, |
||||
| 610 | 26418120 |
US |
65 | |
Incorrect dose administered, Illness, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 611 | 26418218 |
US |
||
Blood glucose increased, |
||||
TIRZEPATIDE, |
||||
| 612 | 26418332 |
US |
67 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 613 | 26418836 |
US |
57 | |
Blood glucose increased, Glomerular filtration rate decreased, |
||||
MIFEPRISTONE, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, GABAPENTIN, HYDROXYZINE, EMPAGLIFLOZIN, LATANOPROST, METHOCARBAMOL, METHOCARBAMOL TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MONTELUKAST, SEMAGLUTIDE, ORAL SEMAGLUTIDE, PRAZOSIN, QUETIAPINE, BREXPIPRAZOLE, ROSUVASTATIN, SERTRALINE, BRINZOLAMIDE/BRIMONIDINE TARTRATE, SPIRONOLACTONE, TIMOLOL, TIZANIDINE, |
||||
| 614 | 26412945 |
US |
2 | |
Blood glucose increased, Asthenia, Dyspnoea, Intensive care, |
||||
CAPIVASERTIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FENTANYL, FUROSEMIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ERGOCALCIFEROL, MIRTAZAPINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FAMOTIDINE, ALENDRONATE SODIUM, |
||||
| 615 | 26413036 |
US |
45 | 2 |
Glycosylated haemoglobin increased, Blood glucose increased, Influenza, Product dose omission issue, Body temperature increased, COVID-19, Neuropathy peripheral, Neuralgia, Asthenia, Vomiting, Sciatica, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO-AABC, INSULIN DEGLUDEC, |
||||
| 616 | 26413300 |
US |
71 | 1 |
Blood glucose increased, Device mechanical issue, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 617 | 26413621 |
US |
||
Blood glucose increased, |
||||
EVOLOCUMAB, |
||||
| 618 | 26414223 |
US |
91 | 1 |
General physical health deterioration, Red blood cell count decreased, Haemoglobin decreased, Haematocrit decreased, Mean cell volume increased, Mean cell haemoglobin increased, Lymphocyte count decreased, Blood glucose increased, Blood creatinine increased, Glomerular filtration rate decreased, Blood albumin decreased, Blood alkaline phosphatase increased, Prostatic specific antigen increased, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 619 | 26414461 |
69 | ||
Blood glucose increased, |
||||
OLEZARSEN SODIUM, PANTOPRAZOLE, ROSUVASTATIN, PREGABALIN, INSULIN LISPRO, INSULIN GLARGINE, ICOSAPENT ETHYL, |
||||
| 620 | 26414556 |
US |
60 | 1 |
Renal cancer, Blood glucose increased, Product dose omission issue, Diarrhoea, Product distribution issue, Product use issue, Blood glucose increased, |
||||
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 621 | 26414859 |
RS |
70 | 1 |
Bladder cancer, Overweight, Blood glucose increased, Hyperuricaemia, Hypertension, |
||||
DAPAGLIFLOZIN, |
||||
| 622 | 26414906 |
US |
71 | 1 |
Off label use, Blood glucose increased, Wrong product administered, |
||||
TIRZEPATIDE, |
||||
| 623 | 26415199 |
US |
71 | 1 |
Visual impairment, Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 624 | 26415211 |
US |
80 | |
Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO-AABC, INSULIN LISPRO-AABC, |
||||
| 625 | 26415238 |
US |
2 | |
Hospitalisation, Asthenia, Fall, Diarrhoea, Blood glucose increased, Eructation, Nasopharyngitis, Dyspepsia, Unevaluable event, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, |
||||
| 626 | 26415335 |
US |
2 | |
Surgery, Biliary colic, Glycosylated haemoglobin increased, Malaise, Blood glucose increased, Ear infection, Headache, Nausea, Vomiting, Decreased appetite, Dizziness, Blood pressure increased, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, |
||||
| 627 | 26415336 |
US |
1 | |
Blood glucose increased, Arthralgia, Hot flush, Illness, Headache, Myalgia, Nausea, Abdominal discomfort, Fatigue, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, TIRZEPATIDE, |
||||
| 628 | 26415343 |
US |
2 | |
Blood glucose increased, Hormone level abnormal, Blood pressure increased, Fatigue, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, |
||||
| 629 | 26415412 |
CH |
73 | 2 |
Headache, Neck pain, Anaemia, Back pain, General physical health deterioration, COVID-19, Dyspnoea exertional, Pain, Blood glucose increased, Haemorrhoids, Chest discomfort, Leukopenia, Leukopenia, Leukopenia, Pneumothorax, Rhinorrhoea, Syncope, Thrombocytopenia, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, CANDESARTAN, |
||||
| 630 | 26415495 |
US |
2 | |
Blood glucose increased, Fatigue, Drug effect less than expected, |
||||
LEVOKETOCONAZOLE, |
||||
| 631 | 26415512 |
US |
2 | |
Tremor, Blood glucose increased, Fatigue, Abdominal distension, Abdominal discomfort, Back pain, Drug ineffective, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, |
||||
| 632 | 26415523 |
US |
53 | 2 |
Hypertension, Blood pressure decreased, Blood glucose increased, Migraine, Rhinorrhoea, Nasopharyngitis, Pyrexia, Sluggishness, Dyspepsia, Fatigue, Dizziness, Diarrhoea, Pain, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, |
||||
| 633 | 26415545 |
US |
1 | |
Blood glucose increased, |
||||
LEVOKETOCONAZOLE, INSULIN GLARGINE, INSULIN LISPRO, PIOGLITAZONE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 634 | 26415675 |
US |
71 | 2 |
Incorrect product administration duration, Blood glucose increased, Product storage error, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 635 | 26415945 |
US |
60 | 2 |
Blood glucose increased, Malaise, Abdominal discomfort, |
||||
INSULIN LISPRO, |
||||
| 636 | 26415952 |
US |
60 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 637 | 26415957 |
US |
1 | |
Dizziness, Herpes zoster, Blood glucose increased, |
||||
| 638 | 26416264 |
US |
69 | 2 |
Blindness, Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 639 | 26416802 |
TR |
8 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 640 | 26416803 |
US |
59 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 641 | 26417064 |
US |
66 | |
COVID-19 pneumonia, Calculus urinary, Infection, Cytopenia, Nephrolithiasis, Polycythaemia vera, Oral pain, Dysphagia, Pruritus, Splenomegaly, Haematuria, Swollen tongue, Myalgia, Hepatic calcification, Back pain, Fall, Arthralgia, Hepatic steatosis, Obesity, Neutrophil count increased, Red cell distribution width increased, White blood cell count increased, Blood urea increased, Blood creatinine increased, Glomerular filtration rate decreased, Globulins decreased, Blood glucose increased, Blood lactate dehydrogenase increased, Haematocrit increased, Renal mass, Pancreatic cyst, Anaemia, Balance disorder, Alanine aminotransferase increased, |
||||
HYDROCORTISONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, ALLOPURINOL, AMLODIPINE, EZETIMIBE, |
||||
| 642 | 26417296 |
US |
91 | |
Hip fracture, Fall, Glycosylated haemoglobin increased, Blood glucose increased, Infusion site scar, |
||||
INSULIN LISPRO, |
||||
| 643 | 26417402 |
US |
80 | 2 |
Cardiac failure, Asthma, Bronchitis, Influenza, Blood glucose increased, Pain of skin, Pruritus, Rash pruritic, |
||||
DULAGLUTIDE, DULAGLUTIDE, HYDROCORTISONE, |
||||
| 644 | 26417457 |
US |
73 | 2 |
Blood glucose increased, Wrong technique in device usage process, Device issue, Off label use, |
||||
INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TIRZEPATIDE, |
||||
| 645 | 26417590 |
US |
82 | 2 |
Blood glucose increased, Pruritus, Rash, |
||||
PEMBROLIZUMAB, |
||||
| 646 | 26417600 |
US |
78 | 1 |
Neuropathy peripheral, Memory impairment, Arthralgia, Arthralgia, Blood glucose increased, Pneumonia, Asthenia, Skin ulcer, Hot flush, |
||||
PEMBROLIZUMAB, |
||||
| 647 | 26417648 |
CO |
71 | 2 |
Hypersensitivity, Off label use, Cystocele, Haemorrhage, Skin burning sensation, Gait disturbance, Chikungunya virus infection, Arthralgia, Skin disorder, General physical health deterioration, Skin exfoliation, Blood glucose increased, Musculoskeletal discomfort, Incoherent, Skin lesion, Liver disorder, Loss of consciousness, Pain, Platelet count decreased, Amnesia, Pruritus, Muscle oedema, Pain of skin, Acne, Pneumonia, Renal disorder, Pseudomonas infection, Erythema, Rash, Renal failure, Illness, Psoriasis, Malaise, Ill-defined disorder, Blood glucose decreased, Movement disorder, Crying, Urinary tract infection, Vaginal haemorrhage, Weight decreased, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, INSULIN GLULISINE, SPIRONOLACTONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 648 | 26417781 |
US |
69 | |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN GLARGINE, |
||||
| 649 | 26417784 |
US |
||
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 650 | 26417846 |
US |
58 | 2 |
Constipation, Abdominal pain upper, Illness, Liver disorder, Anal haemorrhage, Blood glucose increased, |
||||
INSULIN GLARGINE, TIRZEPATIDE, INSULIN DEGLUDEC, |
||||
| 651 | 26407627 |
IR |
4 | 2 |
Hypoxic-ischaemic encephalopathy, Toxicity to various agents, Loss of consciousness, Miosis, Blood glucose increased, Drug abuse, Cough, Vomiting, Nausea, |
||||
METHADONE HYDROCHLORIDE, METHADONE, |
||||
| 652 | 26408137 |
US |
56 | 2 |
Blood glucose increased, Blood cholesterol increased, Visual impairment, Drug ineffective, |
||||
DULAGLUTIDE, DULAGLUTIDE, INSULIN ASPART, |
||||
| 653 | 26408138 |
US |
34 | 2 |
Incorrect dose administered, Blood glucose increased, |
||||
INSULIN LISPRO-AABC, INSULIN GLARGINE, |
||||
| 654 | 26408572 |
US |
65 | 1 |
Blood loss anaemia, Clostridium difficile colitis, Pulmonary embolism, Pneumonia pseudomonal, Colitis ulcerative, Blood calcium decreased, Blood glucose increased, Blood urea increased, Blood chloride increased, Blood albumin decreased, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 655 | 26408961 |
31 | ||
Rheumatoid arthritis, Thyroglobulin increased, Blood immunoglobulin M increased, Blood immunoglobulin G increased, Blood immunoglobulin A increased, Antinuclear antibody increased, Blood glucose increased, Blood creatinine decreased, Therapy interrupted, Insurance issue, Inability to afford medication, |
||||
CERTOLIZUMAB PEGOL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROXYCHLOROQUINE SULFATE, |
||||
| 656 | 26409203 |
|||
Blood glucose increased, Headache, |
||||
CIPROFLOXACIN HYDROCHLORIDE, LOSARTAN, TRIMETHOPRIM, |
||||
| 657 | 26410633 |
US |
71 | 2 |
Blood glucose increased, Device issue, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 658 | 26410676 |
US |
80 | 2 |
Blood glucose increased, Device issue, Inappropriate schedule of product administration, Drug ineffective, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 659 | 26410923 |
US |
73 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 660 | 26410956 |
US |
47 | 2 |
Blood glucose increased, Intentional product misuse, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 661 | 26410985 |
US |
71 | 1 |
Blood glucose increased, Product dose omission issue, Device breakage, |
||||
INSULIN GLARGINE, |
||||
| 662 | 26411116 |
US |
68 | 2 |
Blood glucose increased, Device operational issue, Product storage error, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 663 | 26411203 |
US |
87 | 2 |
Blood glucose increased, Dementia, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 664 | 26411207 |
US |
68 | 1 |
Cerebrovascular accident, Vascular injury, Glaucoma, Loss of consciousness, Product storage error, Wrong technique in product usage process, Blood pressure decreased, Visual impairment, Cellulitis, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 665 | 26411370 |
US |
1 | |
Blood glucose increased, Device malfunction, |
||||
LIRAGLUTIDE, GLIPIZIDE, GLIPIZIDE-TABLETS, |
||||
| 666 | 26411559 |
US |
64 | 1 |
Adrenal insufficiency, Bronchiectasis, Hydroureter, Granuloma, Neutrophil count abnormal, Lymphocyte count abnormal, Eosinophil count abnormal, Pneumonia, Haematocrit abnormal, Mean platelet volume abnormal, Diarrhoea, Blood glucose increased, Protein S increased, Hypothyroidism, Encephalopathy, Pleural effusion, Aortic arteriosclerosis, Haemoglobin abnormal, Red cell distribution width abnormal, Red blood cell count abnormal, Blood glucose abnormal, Blood creatine abnormal, |
||||
PEMBROLIZUMAB, ALLOPURINOL, AMLODIPINE, CEPHALEXIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 667 | 26411757 |
EU |
60 | 1 |
Loss of consciousness, Depressed level of consciousness, Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, BISOPROLOL FUMARATE, LINAGLIPTIN AND METFORMIN HYDROCHLORIDE, ALLOPURINOL, |
||||
| 668 | 26411821 |
US |
52 | 2 |
Anion gap increased, Hyponatraemia, Acute kidney injury, Base excess increased, Blood urea increased, Blood chloride decreased, Blood creatinine increased, Blood glucose increased, Blood bicarbonate increased, Hypokalaemia, Lipase increased, Lactic acidosis, Neutrophil count increased, Blood pH increased, PCO2 abnormal, Device related infection, General physical health deterioration, Red cell distribution width increased, Aspartate aminotransferase increased, Alanine aminotransferase increased, Sepsis, Blood alkaline phosphatase increased, Chills, Intestinal obstruction, Abdominal discomfort, Dizziness, Hypotension, Tachycardia, Cardiac arrest, Nausea, Protein total increased, Sepsis, Pyrexia, Urine output decreased, Vomiting, Asthenia, Dehydration, |
||||
LUTETIUM LU 177 DOTATATE, INSULIN GLARGINE, METHOCARBAMOL, METHOCARBAMOL TABLETS, PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ARTIFICIAL TEARS, LUBRICANT EYE DROPS, POLYVINYL ALCOHOL, POVIDONE, GLYCERIN, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CALCIUM CARBONATE, ANTACID, CEFEPIME HYDROCHLORIDE, CEFEPIME, HYDRALAZINE HYDROCHLORIDE, LABETALOL, MELATONIN, NALOXONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, POLYETHYLENE GLYCOL, SENNOSIDES, SENNA LEAF, SENNA, METHOCARBAMOL, METHOCARBAMOL TABLETS, PANTOPRAZOLE, LANREOTIDE ACETATE, ATROPINE SULFATE, ATROPINE, CEFUROXIME, INSULIN LISPRO, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, GLUCAGON, GLUCAGON, GLUCAGON, CARBOXYMETHYLCELLULOSE SODIUM, |
||||
| 669 | 26411882 |
US |
2 | |
Unevaluable event, Blood glucose increased, |
||||
LIRAGLUTIDE, |
||||
| 670 | 26411945 |
US |
1 | |
Sinus disorder, Blood glucose increased, Nausea, |
||||
LIRAGLUTIDE, INSULIN ASPART, |
||||
| 671 | 26412052 |
US |
55 | 2 |
Urinary tract infection, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
LIRAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 672 | 26412059 |
US |
2 | |
Weight increased, Vitamin D deficiency, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
LIRAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 673 | 26412115 |
US |
1 | |
Eczema, Psoriasis, Weight increased, Blood glucose increased, Blood glucose decreased, Drug ineffective, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, LIRAGLUTIDE, |
||||
| 674 | 26412224 |
US |
2 | |
Diabetic retinopathy, Condition aggravated, Blood glucose increased, Drug ineffective, |
||||
LIRAGLUTIDE, |
||||
| 675 | 26412290 |
US |
1 | |
Blood glucose increased, |
||||
LIRAGLUTIDE, |
||||
| 676 | 26412328 |
US |
1 | |
Blood creatinine increased, Blood glucose increased, |
||||
LIRAGLUTIDE, INSULIN GLARGINE, |
||||
| 677 | 26412357 |
US |
73 | 2 |
Visual impairment, Constipation, Blood glucose increased, Wrong technique in product usage process, |
||||
LIRAGLUTIDE, |
||||
| 678 | 26412436 |
71 | 2 | |
Blood glucose increased, Product dose omission issue, Product administration interrupted, |
||||
METRELEPTIN, |
||||
| 679 | 26412441 |
19 | 2 | |
Blood glucose increased, Blood triglycerides increased, Off label use, |
||||
METRELEPTIN, BACTERIOSTATIC WATER, FENOFIBRATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SERTRALINE HYDROCHLORIDE, LISINOPRIL, ERGOCALCIFEROL, |
||||
| 680 | 26412670 |
EU |
81 | 1 |
Cholecystitis acute, Gallbladder enlargement, Cholecystitis, Vomiting, Abdominal tenderness, Abdominal pain, Hypertension, Sepsis, Acute cholecystitis necrotic, Clostridial infection, Diarrhoea, Klebsiella infection, Focal peritonitis, Urinary tract infection, Liver function test increased, Blood glucose increased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, PREDNISONE, PREDNISONE, |
||||
| 681 | 26412700 |
US |
75 | 1 |
Blood glucose increased, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 682 | 26417375 |
29 | 1 | |
Nausea, Diarrhoea, Abdominal discomfort, Dehydration, Blood glucose increased, |
||||
INSULIN LISPRO, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, ESOMEPRAZOLE MAGNESIUM, GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 683 | 26401188 |
US |
75 | 2 |
Shoulder fracture, Visual impairment, Accidental underdose, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 684 | 26401848 |
EU |
66 | 1 |
Lacunar stroke, Dysarthria, Ataxia, Facial paralysis, Hemihypoaesthesia, Pneumonia, Respiratory syncytial virus infection, Hypertension, Ischaemia, Muscular weakness, Blood glucose increased, |
||||
DUPILUMAB, DUPILUMAB, MOMETASONE FUROATE MONOHYDRATE, MOMETASONE FUROATE MONOHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MONTELUKAST, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, AMLODIPINE, MONTELUKAST SODIUM, MONTELUKAST, MOMETASONE FUROATE MONOHYDRATE, |
||||
| 685 | 26401888 |
US |
92 | 2 |
Blood glucose increased, Memory impairment, Asthenia, Insomnia, |
||||
LINAGLIPTIN, INSULIN GLARGINE, |
||||
| 686 | 26402762 |
US |
89 | 1 |
Visual impairment, Hypoacusis, Gait disturbance, Blood glucose increased, Blood glucose decreased, Intercepted product prescribing error, |
||||
INSULIN HUMAN, INSULIN HUMAN, |
||||
| 687 | 26403026 |
US |
85 | 1 |
Arthralgia, Blood glucose increased, |
||||
POMALIDOMIDE, |
||||
| 688 | 26403291 |
EU |
67 | 1 |
Acute myocardial infarction, Blood cholesterol increased, Low density lipoprotein increased, Blood triglycerides increased, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
INCLISIRAN, ROSUVASTATIN, EZETIMIBE, |
||||
| 689 | 26403416 |
US |
63 | |
Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 690 | 26403458 |
US |
60 | 2 |
Ulcer haemorrhage, Anaemia, Blood glucose increased, Memory impairment, Hypersomnia, Vascular stent thrombosis, |
||||
RIVAROXABAN, MIFEPRISTONE, MIFEPRISTONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ATENOLOL, AZELASTINE, BACLOFEN, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUPROPION, CARBAMAZEPINE, CEVIMELINE HYDROCHLORIDE, DOXEPIN, DOXEPIN HYDROCHLORIDE, EZETIMIBE, GLIMEPIRIDE, EMPAGLIFLOZIN, LISINOPRIL, MELOXICAM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, MONTELUKAST, INSULIN ASPART, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PRUCALOPRIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ROSUVASTATIN CALCIUM, SENNOSIDES, SENNA LEAF, SENNA, TOPIRAMATE, TOPIRAMATE SPINKLE, INSULIN DEGLUDEC, ERGOCALCIFEROL, BREXPIPRAZOLE, SPIRONOLACTONE, MEMANTINE, MEMANTINE HYDROCHLORIDE, DICYCLOMINE HYDROCHLORIDE, FERROUS SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BENZONATATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, BIOTIN, |
||||
| 691 | 26403752 |
US |
45 | 2 |
Blood glucose increased, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 692 | 26404077 |
MD |
70 | 1 |
Asthenia, Decreased appetite, Vomiting, Diarrhoea, Hypertension, Malaise, Blood glucose increased, Condition aggravated, |
||||
SUNITINIB MALATE, |
||||
| 693 | 26404421 |
US |
27 | 1 |
Dyspnoea, Peripheral swelling, Blood glucose increased, Drug ineffective, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, |
||||
| 694 | 26404422 |
US |
17 | 2 |
Blood glucose increased, Oedema peripheral, |
||||
DIAZOXIDE CHOLINE, DIAZOXIDE CHOLINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FAMOTIDINE, |
||||
| 695 | 26404434 |
CN |
34 | 1 |
Gastroenteritis, Blood potassium increased, Blood glucose increased, Blood glucose increased, Prescription drug used without a prescription, Wrong technique in product usage process, Treatment noncompliance, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 696 | 26404450 |
CN |
42 | 1 |
Seizure, Weight decreased, Decreased appetite, Feeling abnormal, Amnesia, Anxiety, Mood altered, Sleep disorder, Insomnia, Blood glucose increased, Trance, White blood cell count increased, Neutrophil count increased, Monocyte count increased, Blood triglycerides increased, Blood uric acid increased, |
||||
INCLISIRAN, |
||||
| 697 | 26404473 |
US |
64 | 2 |
Blood glucose increased, Nasopharyngitis, Sneezing, Extra dose administered, |
||||
DULAGLUTIDE, |
||||
| 698 | 26404505 |
1 | ||
Blood pressure increased, Blood glucose increased, Skin discolouration, Weight increased, Swelling, Abdominal distension, Fatigue, Fluid retention, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 699 | 26404513 |
US |
43 | 2 |
Injection site pain, Injection site induration, Injection site bruising, Blood glucose increased, |
||||
| 700 | 26404578 |
TR |
181 | 2 |
Blood glucose increased, Incorrect dose administered by device, Device issue, |
||||
INSULIN GLARGINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28